Back to Search
Start Over
Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications.
- Source :
- Journal of the American Geriatrics Society; Jan2023, Vol. 71 Issue 1, p89-97, 9p
- Publication Year :
- 2023
-
Abstract
- Background: Antiepileptics are commonly prescribed to nursing home residents with Alzheimer's disease and related dementias (ADRD) but there is little scientific support for their use in this population. It is unclear whether different antiepileptics are targeting different indications. Methods: Using the Minimum Data Set and Medicare data, including Part D pharmacy claims, we constructed annual cohorts of residents with ADRD with long‐term stays in nursing homes from 2015 to 2019. For each year, we measured the proportion of residents with ADRD in nursing homes nationwide with at least one antiepileptic prescription. We also measured trends in valproic acid, gabapentin, antipsychotic, and opioid prescribing. Finally, we examined how prescribing rates differed based on whether residents with ADRD had disruptive behaviors or reported pain. Results: Our study sample includes 973,074 persons living with ADRD who had a long‐term stay in a nursing home, which was defined as at least 3 months. The proportion of residents with ADRD with at least one antiepileptic prescription increased from 29.5% in 2015 to 31.3% in 2019, which was driven by increases in the rate of valproic acid and gabapentin prescribing. Conversely, antipsychotic prescribing rates declined from 32.1% to 27.9% and opioid prescribing rates declined from 39.8% to 31.7%. The risk of valproic acid prescribing was 10.9 percentage points higher among residents with ADRD with disruptive behaviors, while the risk of being prescribed gabapentin was 13.9 percentage points higher among residents with ADRD reporting pain. Conclusions: Antiepileptic prescribing among nursing home residents with ADRD is increasing, while antipsychotic and opioid prescribing is declining. Examining antiepileptic prescribing to residents with ADRD who had disruptive behaviors and/or reported pain suggests that two of the most common antiepileptics, valproic acid and gabapentin, are being used in clinically distinct ways. Antiepileptic prescribing of questionable risk–benefit for dementia care warrants further scrutiny. See related editorial by Carnahan et al. in this issue. [ABSTRACT FROM AUTHOR]
- Subjects :
- ANTICONVULSANTS
FEE for service (Medical fees)
ALZHEIMER'S disease
SCIENTIFIC observation
CONFIDENCE intervals
NURSING home patients
AGE distribution
RACE
BEHAVIOR disorders
DATABASE management
HEALTH insurance reimbursement
RISK assessment
SEX distribution
DRUG prescribing
PSYCHOSOCIAL factors
DESCRIPTIVE statistics
RESEARCH funding
PHYSICIAN practice patterns
AGGRESSION (Psychology)
STATISTICAL models
DATA analysis software
ANTIPSYCHOTIC agents
VALPROIC acid
GABAPENTIN
SENILE dementia
PAIN management
MEDICARE
Subjects
Details
- Language :
- English
- ISSN :
- 00028614
- Volume :
- 71
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Journal of the American Geriatrics Society
- Publication Type :
- Academic Journal
- Accession number :
- 161471890
- Full Text :
- https://doi.org/10.1111/jgs.18119